We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases

    Background

    Breast cancer is the most common malignancy globally, and is considered a major cause of cancer-related death. Tremendous effort is exerted...

    Randa El-Gamal, Sara Elfarrash, ... Mohammed I. El-Gamal in BMC Cancer
    Article Open access 02 November 2023
  2. Anti-cancer potential of substituted “amino-alkyl-rhodamine” derivatives against MCF-7 human breast cancer cell line

    Breast cancer is the most prevalent diagnosed cancer among women and the main cause of morbidity and mortality. As for breast cancer, MCF-7 cells are...

    Padma Charan Behera, Varnita Karmakar, ... Bamaprasad Bag in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 03 January 2023
  3. Targeting cholesterol impairs cell invasion of all breast cancer types

    Background

    Breast cancer clinical outcome relies on its intrinsic molecular subtype and mortality is almost exclusively due to metastasis, whose...

    Mauriane Maja, Marie Verfaillie, ... Donatienne Tyteca in Cancer Cell International
    Article Open access 10 January 2024
  4. linc01152 Regulates Cell Viability, Cell Migration and Cell Invasion of Breast Cancer via Regulating miR-320a and MTDH

    Breast cancer is a global disease and a cause of cancer-related deaths in women. Long non-coding RNAs (lncRNAs) perform important functions in...

    Zhiwei Zhu, Siting Lin, Lihong Pang in Biochemical Genetics
    Article 07 June 2024
  5. Adipocyte–Breast Cancer Cell Co-Culture in Transwells

    Experiments with cell co-culture systems facilitate investigation of the effects of one cell population on another, when the cells are grown in close...
    Soofiyah P. Ayaani, Martin Wabitsch, Mark Christian in Cancer Cell Biology
    Protocol 2022
  6. Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations

    Breast cancer (BC) is the leading cause of cancer-related death in women worldwide. Triple negative breast cancer (TNBC) is the most aggressive form...

    Yudibeth Sixto-López, Cynthia Ordaz-Pichardo, ... José Correa-Basurto in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 25 January 2023
  7. Effect of Rosa damascena Essential Oil Loaded in Nanostructured Lipid Carriers on the Proliferation of Human Breast Cancer Cell Line MDA-MB-231 in Comparison with Cisplatin

    Purpose

    As Rosa damascena essential oils (RDEOs) have antioxidant, antibacterial, antiviral, and insecticidal activity, they could therefore be...

    Elham Yari, Soyar Sari, ... Ali Nokhodchi in Journal of Pharmaceutical Innovation
    Article Open access 19 January 2024
  8. Comparing the toxicity effects of copper oxide nanoparticles conjugated with Lapatinib on breast (MDA-MB-231) and lung (A549) cancer cell lines

    In recent years, the increase in cancer morbidity and mortality has presented scientists with a major challenge in develo** new therapeutic agents...

    Masoumeh Valizadeh Talarposhti, Ali Salehzadeh, Amir Jalali in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 02 April 2024
  9. Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line

    Maria Perez-Lanzon, Maria Chiara Maiuri, ... Guido Kroemer in Genes & Immunity
    Article 13 January 2024
  10. Predictability of B cell clonal persistence and immunosurveillance in breast cancer

    B cells and T cells are important components of the adaptive immune system and mediate anticancer immunity. The T cell landscape in cancer is well...

    Stephen-John Sammut, Jacob D. Galson, ... Rachael J. M. Bashford-Rogers in Nature Immunology
    Article Open access 02 May 2024
  11. microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway

    Breast cancer is a common malignancy in women with poor prognosis. This study aimed to investigate the molecular mechanism of microRNA-944 (miR-944)...

    Ying Zhang, Shan Li, ... Yiliang Wang in Apoptosis
    Article 24 July 2023
  12. Reduced representative methylome profiling of cell-free DNA for breast cancer detection

    Background

    Whole-genome methylation sequencing of cfDNA is not cost-effective for tumor detection. Here, we introduce reduced representative methylome...

    Qingmo Yang, **ngqiang Zhu, ... Hongliang Chen in Clinical Epigenetics
    Article Open access 27 February 2024
  13. CDKs in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer

    One of the deadly diseases in terms of incidence and mortality among females is breast cancer (BC), it is escalating at an alarming rate having...
    Chapter 2023
  14. cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer

    Genomic instability, as caused by oncogene-induced replication stress, can lead to the activation of inflammatory signaling, involving the cGAS-STING...

    Mengting Chen, Shibo Yu, ... Marcel A. T. M. van Vugt in npj Breast Cancer
    Article Open access 02 January 2024
  15. Resistance to Immunotherapy in Breast Cancer

    Breast cancer is the most common and second most deadly disease in women worldwide, with breast cancer screening resulting in a steady decline in...
    Botle Precious Damane, Lorraine Tshegofatso Maebele, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  16. Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines

    Breast cancer is a heterogeneous disease, and breast cancer cell lines are invaluable for studying this heterogeneity. However, the epigenetic...

    Liying Yang, Kohei Kumegawa, ... Reo Maruyama in Cancer Gene Therapy
    Article Open access 01 March 2024
  17. Selective apoptotic and genotoxic effects of pomegranate peel extract against human hepatocellular carcinoma HepG2 cell line

    Finding a therapeutic agent that is selective, non-toxic to normal cells, and does not develop resistance or unpleasant side effects became the most...

    Wesam T. Basal, Medhat El-Sakka, ... Aliaa M. Issa in Advances in Traditional Medicine
    Article 15 May 2024
  18. COPS6 promotes tumor progression and reduces CD8+ T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast cancer

    Due to poor T cell infiltration, tumors evade immune surveillance. Increased CD8 + T cell infiltration in breast cancer suggests a satisfactory...

    Wen-qi Du, Zhi-man Zhu, ... Dong-sheng Pei in Acta Pharmacologica Sinica
    Article 24 April 2023
  19. Immunotherapy in Breast Cancer

    Breast cancer affects 12% of women worldwide. Although advances in systemic, surgical, and radiation therapy approaches will cure a large proportion...
    Jenna Hoppenworth, Roberto A. Leon-Ferre in The Basics of Cancer Immunotherapy
    Chapter 2024
Did you find what you were looking for? Share feedback.